2019
DOI: 10.1038/s41418-019-0400-z
|View full text |Cite
|
Sign up to set email alerts
|

RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
55
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 44 publications
(56 citation statements)
references
References 43 publications
1
55
0
Order By: Relevance
“…In the case of breast cancers, conflicting results were published. Accordingly, immunohistochemistry-based studies linked a high level of HSPA2 in tumor with unfavorable clinicopathological characteristics and shorter overall as well as disease-free survival [ 27 , 47 ]. Instead, analysis of the transcriptomic data showed that a high level of HSPA2 mRNA predicts a favorable outcome [ 48 , 49 , 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the case of breast cancers, conflicting results were published. Accordingly, immunohistochemistry-based studies linked a high level of HSPA2 in tumor with unfavorable clinicopathological characteristics and shorter overall as well as disease-free survival [ 27 , 47 ]. Instead, analysis of the transcriptomic data showed that a high level of HSPA2 mRNA predicts a favorable outcome [ 48 , 49 , 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…The up regulation of hnRNP-K transcriptional activity mediated by SERPINA3 promotes the survival and proliferation of HCC cells, which may be an indicator of poor prognosis in HCC patients (17). Heat shock protein family a member 2 (HSPA2), a putative oncoprotein, is often up-regulated in human cancers and promotes tumor growth and progression (18). NFKBIE aberrations are common genetic events in trans-b-cell malignancies, and NFKBIE deletion is a new marker of poor prognosis in primary mediastinal B-cell lymphoma (PMBL) (19).…”
Section: Discussionmentioning
confidence: 99%
“…To validate the reliability of HSPA2 detection in cellular environment highly enriched in stress-inducible HSPAs, we evoked proteotoxic stress in MCF7 cells using MG132, a reversible proteasome inhibitor. We used MCF7 cells, since a massive accumulation of HSPA2 following MG132 treatment can be detected in these cells, as shown recently using the Proteintech antibody [9]. For detection of stress-inducible HSPA1 and HSPA6, and constitutive HSPA8, we used commercial antibodies (Table 3).…”
Section: Detection Of the Endogenous Hspa2 In Cells Under Proteotoxicmentioning
confidence: 99%
“…In this aspect, the usage of validated primary antibody is an absolute must to obtain reliable results. The IHC technique was used in several studies aimed at evaluating HSPA2 as potential cancer biomarker (details in Table 1) [9,12,14,16,17]. However, in only one of these studies [12] was an anti-HSPA2 antibody with previously proven specificity used [15].…”
Section: The Impact Of Anti-hspa2 Antibody Used For Ihc Detection Onmentioning
confidence: 99%
See 1 more Smart Citation